The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Passive Digital Biomarker Market Research Report 2025
Synopsis
Passive digital biomarkers are individual biological and behavioral data collected passively (passively) through digital technologies, sensors, and smart devices. These data can include physiological parameters (e.g., heart rate, sleep quality, exercise), behavioral activities (e.g., walking, daily activities), environmental factors (e.g., ambient temperature, air quality), etc.
The global Passive Digital Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Passive Digital Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Passive Digital Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Passive Digital Biomarker include Pfizer, Philips, Novartis, Johnson & Johnson, GlaxoSmithKline, GE Healthcare, Asahi Kasei, Abbott Laboratories and Merck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Passive Digital Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Passive Digital Biomarker.
Report Scope
The Passive Digital Biomarker market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Passive Digital Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Passive Digital Biomarker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Philips
Novartis
Johnson & Johnson
GlaxoSmithKline
GE Healthcare
Asahi Kasei
Abbott Laboratories
Merck
Bayer
Sanofi
Koneksa Health
Huma Therapeutics
Roche
Biogen
Segment by Type
Physiological Parameters Type
Behavioral Activity Type
Environmental Factors Type
Others
Segment by Application
Health Management
Disease Prevention
Clinical Diagnosis
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Passive Digital Biomarker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Passive Digital Biomarker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Passive digital biomarkers are individual biological and behavioral data collected passively (passively) through digital technologies, sensors, and smart devices. These data can include physiological parameters (e.g., heart rate, sleep quality, exercise), behavioral activities (e.g., walking, daily activities), environmental factors (e.g., ambient temperature, air quality), etc.
The global Passive Digital Biomarker market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Passive Digital Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Passive Digital Biomarker is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Passive Digital Biomarker include Pfizer, Philips, Novartis, Johnson & Johnson, GlaxoSmithKline, GE Healthcare, Asahi Kasei, Abbott Laboratories and Merck, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Passive Digital Biomarker, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Passive Digital Biomarker.
Report Scope
The Passive Digital Biomarker market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Passive Digital Biomarker market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Passive Digital Biomarker manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Pfizer
Philips
Novartis
Johnson & Johnson
GlaxoSmithKline
GE Healthcare
Asahi Kasei
Abbott Laboratories
Merck
Bayer
Sanofi
Koneksa Health
Huma Therapeutics
Roche
Biogen
Segment by Type
Physiological Parameters Type
Behavioral Activity Type
Environmental Factors Type
Others
Segment by Application
Health Management
Disease Prevention
Clinical Diagnosis
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Southeast Asia
China Taiwan
Australia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Passive Digital Biomarker manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Passive Digital Biomarker in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Passive Digital Biomarker Market Overview
1.1 Product Overview and Scope of Passive Digital Biomarker
1.2 Passive Digital Biomarker Segment by Type
1.2.1 Global Passive Digital Biomarker Market Value Comparison by Type (2024-2030)
1.2.2 Physiological Parameters Type
1.2.3 Behavioral Activity Type
1.2.4 Environmental Factors Type
1.2.5 Others
1.3 Passive Digital Biomarker Segment by Application
1.3.1 Global Passive Digital Biomarker Market Value by Application: (2024-2030)
1.3.2 Health Management
1.3.3 Disease Prevention
1.3.4 Clinical Diagnosis
1.3.5 Others
1.4 Global Passive Digital Biomarker Market Size Estimates and Forecasts
1.4.1 Global Passive Digital Biomarker Revenue 2019-2030
1.4.2 Global Passive Digital Biomarker Sales 2019-2030
1.4.3 Global Passive Digital Biomarker Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Passive Digital Biomarker Market Competition by Manufacturers
2.1 Global Passive Digital Biomarker Sales Market Share by Manufacturers (2019-2024)
2.2 Global Passive Digital Biomarker Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Passive Digital Biomarker Average Price by Manufacturers (2019-2024)
2.4 Global Passive Digital Biomarker Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Passive Digital Biomarker, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Passive Digital Biomarker, Product Type & Application
2.7 Passive Digital Biomarker Market Competitive Situation and Trends
2.7.1 Passive Digital Biomarker Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Passive Digital Biomarker Players Market Share by Revenue
2.7.3 Global Passive Digital Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Passive Digital Biomarker Retrospective Market Scenario by Region
3.1 Global Passive Digital Biomarker Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Passive Digital Biomarker Global Passive Digital Biomarker Sales by Region: 2019-2030
3.2.1 Global Passive Digital Biomarker Sales by Region: 2019-2024
3.2.2 Global Passive Digital Biomarker Sales by Region: 2025-2030
3.3 Global Passive Digital Biomarker Global Passive Digital Biomarker Revenue by Region: 2019-2030
3.3.1 Global Passive Digital Biomarker Revenue by Region: 2019-2024
3.3.2 Global Passive Digital Biomarker Revenue by Region: 2025-2030
3.4 North America Passive Digital Biomarker Market Facts & Figures by Country
3.4.1 North America Passive Digital Biomarker Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Passive Digital Biomarker Sales by Country (2019-2030)
3.4.3 North America Passive Digital Biomarker Revenue by Country (2019-2030)
3.4.4 United States
3.4.5 Canada
3.5 Europe Passive Digital Biomarker Market Facts & Figures by Country
3.5.1 Europe Passive Digital Biomarker Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Passive Digital Biomarker Sales by Country (2019-2030)
3.5.3 Europe Passive Digital Biomarker Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Netherlands
3.6 Asia Pacific Passive Digital Biomarker Market Facts & Figures by Country
3.6.1 Asia Pacific Passive Digital Biomarker Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Passive Digital Biomarker Sales by Country (2019-2030)
3.6.3 Asia Pacific Passive Digital Biomarker Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Southeast Asia
3.6.9 China Taiwan
3.6.10 Australia
3.7 Latin America Passive Digital Biomarker Market Facts & Figures by Country
3.7.1 Latin America Passive Digital Biomarker Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Passive Digital Biomarker Sales by Country (2019-2030)
3.7.3 Latin America Passive Digital Biomarker Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Passive Digital Biomarker Market Facts & Figures by Country
3.8.1 Middle East and Africa Passive Digital Biomarker Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Passive Digital Biomarker Sales by Country (2019-2030)
3.8.3 Middle East and Africa Passive Digital Biomarker Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Passive Digital Biomarker Sales by Type (2019-2030)
4.1.1 Global Passive Digital Biomarker Sales by Type (2019-2024)
4.1.2 Global Passive Digital Biomarker Sales by Type (2025-2030)
4.1.3 Global Passive Digital Biomarker Sales Market Share by Type (2019-2030)
4.2 Global Passive Digital Biomarker Revenue by Type (2019-2030)
4.2.1 Global Passive Digital Biomarker Revenue by Type (2019-2024)
4.2.2 Global Passive Digital Biomarker Revenue by Type (2025-2030)
4.2.3 Global Passive Digital Biomarker Revenue Market Share by Type (2019-2030)
4.3 Global Passive Digital Biomarker Price by Type (2019-2030)
5 Segment by Application
5.1 Global Passive Digital Biomarker Sales by Application (2019-2030)
5.1.1 Global Passive Digital Biomarker Sales by Application (2019-2024)
5.1.2 Global Passive Digital Biomarker Sales by Application (2025-2030)
5.1.3 Global Passive Digital Biomarker Sales Market Share by Application (2019-2030)
5.2 Global Passive Digital Biomarker Revenue by Application (2019-2030)
5.2.1 Global Passive Digital Biomarker Revenue by Application (2019-2024)
5.2.2 Global Passive Digital Biomarker Revenue by Application (2025-2030)
5.2.3 Global Passive Digital Biomarker Revenue Market Share by Application (2019-2030)
5.3 Global Passive Digital Biomarker Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Passive Digital Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Pfizer Passive Digital Biomarker Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Philips
6.2.1 Philips Corporation Information
6.2.2 Philips Description and Business Overview
6.2.3 Philips Passive Digital Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Philips Passive Digital Biomarker Product Portfolio
6.2.5 Philips Recent Developments/Updates
6.3 Novartis
6.3.1 Novartis Corporation Information
6.3.2 Novartis Description and Business Overview
6.3.3 Novartis Passive Digital Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Novartis Passive Digital Biomarker Product Portfolio
6.3.5 Novartis Recent Developments/Updates
6.4 Johnson & Johnson
6.4.1 Johnson & Johnson Corporation Information
6.4.2 Johnson & Johnson Description and Business Overview
6.4.3 Johnson & Johnson Passive Digital Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Johnson & Johnson Passive Digital Biomarker Product Portfolio
6.4.5 Johnson & Johnson Recent Developments/Updates
6.5 GlaxoSmithKline
6.5.1 GlaxoSmithKline Corporation Information
6.5.2 GlaxoSmithKline Description and Business Overview
6.5.3 GlaxoSmithKline Passive Digital Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.5.4 GlaxoSmithKline Passive Digital Biomarker Product Portfolio
6.5.5 GlaxoSmithKline Recent Developments/Updates
6.6 GE Healthcare
6.6.1 GE Healthcare Corporation Information
6.6.2 GE Healthcare Description and Business Overview
6.6.3 GE Healthcare Passive Digital Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.6.4 GE Healthcare Passive Digital Biomarker Product Portfolio
6.6.5 GE Healthcare Recent Developments/Updates
6.7 Asahi Kasei
6.6.1 Asahi Kasei Corporation Information
6.6.2 Asahi Kasei Description and Business Overview
6.6.3 Asahi Kasei Passive Digital Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Asahi Kasei Passive Digital Biomarker Product Portfolio
6.7.5 Asahi Kasei Recent Developments/Updates
6.8 Abbott Laboratories
6.8.1 Abbott Laboratories Corporation Information
6.8.2 Abbott Laboratories Description and Business Overview
6.8.3 Abbott Laboratories Passive Digital Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Abbott Laboratories Passive Digital Biomarker Product Portfolio
6.8.5 Abbott Laboratories Recent Developments/Updates
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck Passive Digital Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Merck Passive Digital Biomarker Product Portfolio
6.9.5 Merck Recent Developments/Updates
6.10 Bayer
6.10.1 Bayer Corporation Information
6.10.2 Bayer Description and Business Overview
6.10.3 Bayer Passive Digital Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Bayer Passive Digital Biomarker Product Portfolio
6.10.5 Bayer Recent Developments/Updates
6.11 Sanofi
6.11.1 Sanofi Corporation Information
6.11.2 Sanofi Passive Digital Biomarker Description and Business Overview
6.11.3 Sanofi Passive Digital Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.11.4 Sanofi Passive Digital Biomarker Product Portfolio
6.11.5 Sanofi Recent Developments/Updates
6.12 Koneksa Health
6.12.1 Koneksa Health Corporation Information
6.12.2 Koneksa Health Passive Digital Biomarker Description and Business Overview
6.12.3 Koneksa Health Passive Digital Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.12.4 Koneksa Health Passive Digital Biomarker Product Portfolio
6.12.5 Koneksa Health Recent Developments/Updates
6.13 Huma Therapeutics
6.13.1 Huma Therapeutics Corporation Information
6.13.2 Huma Therapeutics Passive Digital Biomarker Description and Business Overview
6.13.3 Huma Therapeutics Passive Digital Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.13.4 Huma Therapeutics Passive Digital Biomarker Product Portfolio
6.13.5 Huma Therapeutics Recent Developments/Updates
6.14 Roche
6.14.1 Roche Corporation Information
6.14.2 Roche Passive Digital Biomarker Description and Business Overview
6.14.3 Roche Passive Digital Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.14.4 Roche Passive Digital Biomarker Product Portfolio
6.14.5 Roche Recent Developments/Updates
6.15 Biogen
6.15.1 Biogen Corporation Information
6.15.2 Biogen Passive Digital Biomarker Description and Business Overview
6.15.3 Biogen Passive Digital Biomarker Sales, Revenue and Gross Margin (2019-2024)
6.15.4 Biogen Passive Digital Biomarker Product Portfolio
6.15.5 Biogen Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Passive Digital Biomarker Industry Chain Analysis
7.2 Passive Digital Biomarker Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Passive Digital Biomarker Production Mode & Process
7.4 Passive Digital Biomarker Sales and Marketing
7.4.1 Passive Digital Biomarker Sales Channels
7.4.2 Passive Digital Biomarker Distributors
7.5 Passive Digital Biomarker Customers
8 Passive Digital Biomarker Market Dynamics
8.1 Passive Digital Biomarker Industry Trends
8.2 Passive Digital Biomarker Market Drivers
8.3 Passive Digital Biomarker Market Challenges
8.4 Passive Digital Biomarker Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Passive Digital Biomarker Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Passive Digital Biomarker Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Passive Digital Biomarker Market Competitive Situation by Manufacturers in 2023
Table 4. Global Passive Digital Biomarker Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Passive Digital Biomarker Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Passive Digital Biomarker Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Passive Digital Biomarker Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Passive Digital Biomarker Average Price (US$/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Passive Digital Biomarker, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Passive Digital Biomarker, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Passive Digital Biomarker, Product Type & Application
Table 12. Global Key Manufacturers of Passive Digital Biomarker, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Passive Digital Biomarker by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Passive Digital Biomarker as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Passive Digital Biomarker Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Passive Digital Biomarker Sales by Region (2019-2024) & (K Units)
Table 18. Global Passive Digital Biomarker Sales Market Share by Region (2019-2024)
Table 19. Global Passive Digital Biomarker Sales by Region (2025-2030) & (K Units)
Table 20. Global Passive Digital Biomarker Sales Market Share by Region (2025-2030)
Table 21. Global Passive Digital Biomarker Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Passive Digital Biomarker Revenue Market Share by Region (2019-2024)
Table 23. Global Passive Digital Biomarker Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Passive Digital Biomarker Revenue Market Share by Region (2025-2030)
Table 25. North America Passive Digital Biomarker Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Passive Digital Biomarker Sales by Country (2019-2024) & (K Units)
Table 27. North America Passive Digital Biomarker Sales by Country (2025-2030) & (K Units)
Table 28. North America Passive Digital Biomarker Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Passive Digital Biomarker Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Passive Digital Biomarker Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Passive Digital Biomarker Sales by Country (2019-2024) & (K Units)
Table 32. Europe Passive Digital Biomarker Sales by Country (2025-2030) & (K Units)
Table 33. Europe Passive Digital Biomarker Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Passive Digital Biomarker Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Passive Digital Biomarker Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Passive Digital Biomarker Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Passive Digital Biomarker Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Passive Digital Biomarker Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Passive Digital Biomarker Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Passive Digital Biomarker Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Passive Digital Biomarker Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Passive Digital Biomarker Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Passive Digital Biomarker Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Passive Digital Biomarker Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Passive Digital Biomarker Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Passive Digital Biomarker Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Passive Digital Biomarker Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Passive Digital Biomarker Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Passive Digital Biomarker Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Passive Digital Biomarker Sales (K Units) by Type (2019-2024)
Table 51. Global Passive Digital Biomarker Sales (K Units) by Type (2025-2030)
Table 52. Global Passive Digital Biomarker Sales Market Share by Type (2019-2024)
Table 53. Global Passive Digital Biomarker Sales Market Share by Type (2025-2030)
Table 54. Global Passive Digital Biomarker Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Passive Digital Biomarker Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Passive Digital Biomarker Revenue Market Share by Type (2019-2024)
Table 57. Global Passive Digital Biomarker Revenue Market Share by Type (2025-2030)
Table 58. Global Passive Digital Biomarker Price (US$/Unit) by Type (2019-2024)
Table 59. Global Passive Digital Biomarker Price (US$/Unit) by Type (2025-2030)
Table 60. Global Passive Digital Biomarker Sales (K Units) by Application (2019-2024)
Table 61. Global Passive Digital Biomarker Sales (K Units) by Application (2025-2030)
Table 62. Global Passive Digital Biomarker Sales Market Share by Application (2019-2024)
Table 63. Global Passive Digital Biomarker Sales Market Share by Application (2025-2030)
Table 64. Global Passive Digital Biomarker Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Passive Digital Biomarker Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Passive Digital Biomarker Revenue Market Share by Application (2019-2024)
Table 67. Global Passive Digital Biomarker Revenue Market Share by Application (2025-2030)
Table 68. Global Passive Digital Biomarker Price (US$/Unit) by Application (2019-2024)
Table 69. Global Passive Digital Biomarker Price (US$/Unit) by Application (2025-2030)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Passive Digital Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 73. Pfizer Passive Digital Biomarker Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Philips Corporation Information
Table 76. Philips Description and Business Overview
Table 77. Philips Passive Digital Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 78. Philips Passive Digital Biomarker Product
Table 79. Philips Recent Developments/Updates
Table 80. Novartis Corporation Information
Table 81. Novartis Description and Business Overview
Table 82. Novartis Passive Digital Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 83. Novartis Passive Digital Biomarker Product
Table 84. Novartis Recent Developments/Updates
Table 85. Johnson & Johnson Corporation Information
Table 86. Johnson & Johnson Description and Business Overview
Table 87. Johnson & Johnson Passive Digital Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 88. Johnson & Johnson Passive Digital Biomarker Product
Table 89. Johnson & Johnson Recent Developments/Updates
Table 90. GlaxoSmithKline Corporation Information
Table 91. GlaxoSmithKline Description and Business Overview
Table 92. GlaxoSmithKline Passive Digital Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 93. GlaxoSmithKline Passive Digital Biomarker Product
Table 94. GlaxoSmithKline Recent Developments/Updates
Table 95. GE Healthcare Corporation Information
Table 96. GE Healthcare Description and Business Overview
Table 97. GE Healthcare Passive Digital Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 98. GE Healthcare Passive Digital Biomarker Product
Table 99. GE Healthcare Recent Developments/Updates
Table 100. Asahi Kasei Corporation Information
Table 101. Asahi Kasei Description and Business Overview
Table 102. Asahi Kasei Passive Digital Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 103. Asahi Kasei Passive Digital Biomarker Product
Table 104. Asahi Kasei Recent Developments/Updates
Table 105. Abbott Laboratories Corporation Information
Table 106. Abbott Laboratories Description and Business Overview
Table 107. Abbott Laboratories Passive Digital Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 108. Abbott Laboratories Passive Digital Biomarker Product
Table 109. Abbott Laboratories Recent Developments/Updates
Table 110. Merck Corporation Information
Table 111. Merck Description and Business Overview
Table 112. Merck Passive Digital Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 113. Merck Passive Digital Biomarker Product
Table 114. Merck Recent Developments/Updates
Table 115. Bayer Corporation Information
Table 116. Bayer Description and Business Overview
Table 117. Bayer Passive Digital Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 118. Bayer Passive Digital Biomarker Product
Table 119. Bayer Recent Developments/Updates
Table 120. Sanofi Corporation Information
Table 121. Sanofi Description and Business Overview
Table 122. Sanofi Passive Digital Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 123. Sanofi Passive Digital Biomarker Product
Table 124. Sanofi Recent Developments/Updates
Table 125. Koneksa Health Corporation Information
Table 126. Koneksa Health Description and Business Overview
Table 127. Koneksa Health Passive Digital Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 128. Koneksa Health Passive Digital Biomarker Product
Table 129. Koneksa Health Recent Developments/Updates
Table 130. Huma Therapeutics Corporation Information
Table 131. Huma Therapeutics Description and Business Overview
Table 132. Huma Therapeutics Passive Digital Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 133. Huma Therapeutics Passive Digital Biomarker Product
Table 134. Huma Therapeutics Recent Developments/Updates
Table 135. Roche Corporation Information
Table 136. Roche Description and Business Overview
Table 137. Roche Passive Digital Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 138. Roche Passive Digital Biomarker Product
Table 139. Roche Recent Developments/Updates
Table 140. Biogen Corporation Information
Table 141. Biogen Description and Business Overview
Table 142. Biogen Passive Digital Biomarker Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 143. Biogen Passive Digital Biomarker Product
Table 144. Biogen Recent Developments/Updates
Table 145. Key Raw Materials Lists
Table 146. Raw Materials Key Suppliers Lists
Table 147. Passive Digital Biomarker Distributors List
Table 148. Passive Digital Biomarker Customers List
Table 149. Passive Digital Biomarker Market Trends
Table 150. Passive Digital Biomarker Market Drivers
Table 151. Passive Digital Biomarker Market Challenges
Table 152. Passive Digital Biomarker Market Restraints
Table 153. Research Programs/Design for This Report
Table 154. Key Data Information from Secondary Sources
Table 155. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Passive Digital Biomarker
Figure 2. Global Passive Digital Biomarker Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Passive Digital Biomarker Market Share by Type in 2023 & 2030
Figure 4. Physiological Parameters Type Product Picture
Figure 5. Behavioral Activity Type Product Picture
Figure 6. Environmental Factors Type Product Picture
Figure 7. Others Product Picture
Figure 8. Global Passive Digital Biomarker Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 9. Global Passive Digital Biomarker Market Share by Application in 2023 & 2030
Figure 10. Health Management
Figure 11. Disease Prevention
Figure 12. Clinical Diagnosis
Figure 13. Others
Figure 14. Global Passive Digital Biomarker Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 15. Global Passive Digital Biomarker Market Size (2019-2030) & (US$ Million)
Figure 16. Global Passive Digital Biomarker Sales (2019-2030) & (K Units)
Figure 17. Global Passive Digital Biomarker Average Price (US$/Unit) & (2019-2030)
Figure 18. Passive Digital Biomarker Report Years Considered
Figure 19. Passive Digital Biomarker Sales Share by Manufacturers in 2023
Figure 20. Global Passive Digital Biomarker Revenue Share by Manufacturers in 2023
Figure 21. The Global 5 and 10 Largest Passive Digital Biomarker Players: Market Share by Revenue in 2023
Figure 22. Passive Digital Biomarker Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 23. Global Passive Digital Biomarker Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 24. North America Passive Digital Biomarker Sales Market Share by Country (2019-2030)
Figure 25. North America Passive Digital Biomarker Revenue Market Share by Country (2019-2030)
Figure 26. United States Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 27. Canada Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. Europe Passive Digital Biomarker Sales Market Share by Country (2019-2030)
Figure 29. Europe Passive Digital Biomarker Revenue Market Share by Country (2019-2030)
Figure 30. Germany Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. France Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. U.K. Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 33. Italy Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 34. Netherlands Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Asia Pacific Passive Digital Biomarker Sales Market Share by Region (2019-2030)
Figure 36. Asia Pacific Passive Digital Biomarker Revenue Market Share by Region (2019-2030)
Figure 37. China Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Japan Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. South Korea Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. India Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Southeast Asia Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. China Taiwan Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Australia Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Passive Digital Biomarker Sales Market Share by Country (2019-2030)
Figure 45. Latin America Passive Digital Biomarker Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Colombia Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 50. Middle East & Africa Passive Digital Biomarker Sales Market Share by Country (2019-2030)
Figure 51. Middle East & Africa Passive Digital Biomarker Revenue Market Share by Country (2019-2030)
Figure 52. Turkey Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. Saudi Arabia Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. UAE Passive Digital Biomarker Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 55. Global Sales Market Share of Passive Digital Biomarker by Type (2019-2030)
Figure 56. Global Revenue Market Share of Passive Digital Biomarker by Type (2019-2030)
Figure 57. Global Passive Digital Biomarker Price (US$/Unit) by Type (2019-2030)
Figure 58. Global Sales Market Share of Passive Digital Biomarker by Application (2019-2030)
Figure 59. Global Revenue Market Share of Passive Digital Biomarker by Application (2019-2030)
Figure 60. Global Passive Digital Biomarker Price (US$/Unit) by Application (2019-2030)
Figure 61. Passive Digital Biomarker Value Chain
Figure 62. Passive Digital Biomarker Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
